Report Central Asia - Antisera and Other Blood Fractions - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Central Asia - Antisera and Other Blood Fractions - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Central Asia: Antisera Market 2024

Antisera Market Size in Central Asia

The Central Asian antisera market was estimated at $X in 2021, rising by 14% against the previous year. Over the period under review, consumption, however, posted a prominent increase. The level of consumption peaked in 2021 and is likely to see steady growth in the immediate term.

Antisera Production in Central Asia

In value terms, antisera production fell to $X in 2021 estimated in export price. Overall, production, however, posted a prominent increase. The pace of growth appeared the most rapid in 2018 when the production volume increased by 89%. The level of production peaked at $X in 2020, and then declined in the following year.

Antisera Exports

Exports in Central Asia

In 2021, approx. X tons of antisera and other blood fractions were exported in Central Asia; with an increase of 1,339% on 2020. In general, exports saw significant growth. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

In value terms, antisera exports soared to $X in 2021. Over the period under review, exports recorded significant growth. The most prominent rate of growth was recorded in 2014 when exports increased by 957% against the previous year. The level of export peaked in 2021 and is expected to retain growth in the near future.

Exports by Country

Kazakhstan represented the major exporter of antisera and other blood fractions in Central Asia, with the volume of exports accounting for X tons, which was near 77% of total exports in 2021. It was distantly followed by Uzbekistan (X tons), mixing up a 23% share of total exports.

Exports from Kazakhstan increased at an average annual rate of +47.1% from 2012 to 2021. At the same time, Uzbekistan (+277.8%) displayed positive paces of growth. Moreover, Uzbekistan emerged as the fastest-growing exporter exported in Central Asia, with a CAGR of +277.8% from 2012-2021. Uzbekistan (+23 p.p.) significantly strengthened its position in terms of the total exports, while Kazakhstan saw its share reduced by -6.6% from 2012 to 2021, respectively.

In value terms, Kazakhstan ($X) remains the largest antisera supplier in Central Asia, comprising 78% of total exports. The second position in the ranking was taken by Uzbekistan ($X), with a 22% share of total exports.

From 2012 to 2021, the average annual growth rate of value in Kazakhstan amounted to +24.0%.

Export Prices by Country

In 2021, the export price in Central Asia amounted to $X per kg, dropping by -68.1% against the previous year. In general, the export price recorded a deep downturn. The most prominent rate of growth was recorded in 2014 when the export price increased by 361%. As a result, the export price attained the peak level of $X per kg. From 2015 to 2021, the export prices failed to regain momentum.

Average prices varied noticeably amongst the major exporting countries. In 2021, the country with the highest price was Kazakhstan ($X per kg), while Uzbekistan stood at $X per kg.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Kazakhstan (-15.7%).

Antisera Imports

Imports in Central Asia

For the fourth consecutive year, Central Asia recorded growth in purchases abroad of antisera and other blood fractions, which increased by 7.6% to X tons in 2021. Over the period under review, imports posted prominent growth. The most prominent rate of growth was recorded in 2014 with an increase of 89%. The volume of import peaked in 2021 and is likely to continue growth in the near future.

In value terms, antisera imports surged to $X in 2021. Overall, imports continue to indicate a buoyant increase. As a result, imports attained the peak and are likely to continue growth in the immediate term.

Imports by Country

Kazakhstan was the major importer of antisera and other blood fractions in Central Asia, with the volume of imports finishing at X tons, which was near 52% of total imports in 2021. It was distantly followed by Uzbekistan (X tons), Tajikistan (X tons), Mongolia (X tons), Turkmenistan (X tons) and Kyrgyzstan (X tons), together generating a 48% share of total imports.

Imports into Kazakhstan increased at an average annual rate of +8.9% from 2012 to 2021. At the same time, Uzbekistan (+26.1%), Mongolia (+25.0%), Tajikistan (+18.3%), Turkmenistan (+9.1%) and Kyrgyzstan (+1.7%) displayed positive paces of growth. Moreover, Uzbekistan emerged as the fastest-growing importer imported in Central Asia, with a CAGR of +26.1% from 2012-2021. From 2012 to 2021, the share of Uzbekistan, Tajikistan and Mongolia increased by +20, +4.4 and +3.8 percentage points, respectively.

In value terms, Kazakhstan ($X) constitutes the largest market for imported antisera and other blood fractions in Central Asia, comprising 86% of total imports. The second position in the ranking was held by Uzbekistan ($X), with a 7.2% share of total imports. It was followed by Mongolia, with a 2% share.

In Kazakhstan, antisera imports expanded at an average annual rate of +14.1% over the period from 2012-2021. In the other countries, the average annual rates were as follows: Uzbekistan (+33.7% per year) and Mongolia (+19.3% per year).

Import Prices by Country

The import price in Central Asia stood at $X per ton in 2021, surging by 53% against the previous year. Import price indicated a mild expansion from 2012 to 2021: its price increased at an average annual rate of +1.8% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, antisera import price increased by +41.9% against 2018 indices. As a result, import price reached the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably country of destination: the country with the highest price was Kazakhstan ($X per ton), while Tajikistan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Uzbekistan (+6.0%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

Kazakhstan constituted the country with the largest volume of antisera consumption, accounting for 59% of total volume. Moreover, antisera consumption in Kazakhstan exceeded the figures recorded by the second-largest consumer, Uzbekistan, threefold. The third position in this ranking was occupied by Mongolia, with a 10% share.
Kazakhstan remains the largest antisera producing country in Central Asia, comprising approx. 82% of total volume. Moreover, antisera production in Kazakhstan exceeded the figures recorded by the second-largest producer, Mongolia, fivefold.
In value terms, Kazakhstan remains the largest antisera supplier in Central Asia, comprising 73% of total exports. The second position in the ranking was occupied by Uzbekistan, with a 27% share of total exports.
In value terms, Kazakhstan constitutes the largest market for imported antisera and other blood fractions in Central Asia, comprising 74% of total imports. The second position in the ranking was occupied by Uzbekistan, with an 11% share of total imports. It was followed by Mongolia, with a 5.3% share.
In 2020, the antisera export price in Central Asia amounted to $986,960 per ton, growing by 2,900% against the previous year.
The antisera import price in Central Asia stood at $432,407 per ton in 2020, falling by -12.7% against the previous year.

This report provides an in-depth analysis of the antisera market in Central Asia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21202125 - Antisera, other immunological products which are directly involved in the regulation of immunological processes and other blood fractions

Country coverage:

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Production in Central Asia, split by region and country
  • Trade (exports and imports) in Central Asia
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY
  8. 8. IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • Kazakhstan
    • Kyrgyzstan
    • Mongolia
    • Tajikistan
    • Turkmenistan
    • Uzbekistan
  12. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption, By Country, 2018–2023
    5. Production, In Physical Terms, By Country, 2012–2023
    6. Imports, In Physical Terms, By Country, 2012–2023
    7. Imports, In Value Terms, By Country, 2012–2023
    8. Import Prices, By Country Of Destination, 2012–2023
    9. Exports, In Physical Terms, By Country, 2012–2023
    10. Exports, In Value Terms, By Country, 2012–2023
    11. Export Prices, By Country Of Origin, 2012–2023
  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Consumption, By Country, 2023
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2023
    18. Production, In Value Terms, 2012–2023
    19. Production, By Country, 2023
    20. Production, In Physical Terms, By Country, 2012–2023
    21. Imports, In Physical Terms, 2012–2023
    22. Imports, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, By Country, 2023
    24. Imports, In Physical Terms, By Country, 2012–2023
    25. Imports, In Value Terms, By Country, 2012–2023
    26. Import Prices, By Country, 2012–2023
    27. Exports, In Physical Terms, 2012–2023
    28. Exports, In Value Terms, 2012–2023
    29. Exports, In Physical Terms, By Country, 2023
    30. Exports, In Physical Terms, By Country, 2012–2023
    31. Exports, In Value Terms, By Country, 2012–2023
    32. Export Prices, 2012–2023

Recommended reports

Free Data: Antisera And Other Blood Fractions - Central Asia